Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal women
- 30 April 1991
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 62 (1-2) , 1-8
- https://doi.org/10.1016/0049-3848(91)90663-h
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Antithrombin III and procoagulant activity: sex differences and effects of the menopauseBritish Journal of Haematology, 1990
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Estrogen Replacement TherapyClinical Obstetrics and Gynecology, 1986
- Atherosclerosis and HemostasisSeminars in Thrombosis and Hemostasis, 1986
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Clinical Relevance of Antithrombin IIISeminars in Thrombosis and Hemostasis, 1982
- At III content and antithrombin activity in oestrogen-progestogen and progestogen-only treated womenThrombosis Research, 1980
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- Fibrin(ogen), platelets and a new theory of atherogenesisThrombosis Research, 1979
- ANTITHROMBIN III AND HEPARINBritish Medical Bulletin, 1978